Oncology Recent advancements in cancer immunotherapeutics BOSTON UNIVERSITY Hee-Young Park KimSusieCancer affects a wide range of organs and tissues within the body and epidemiologically is forecasted to affect almost half of the world's population. As an industry, cancer therapeutics represent a ...
Cancer immunotherapy has emerged as a novel cancer treatment, although recent immunotherapy trials have produced suboptimal outcomes, with durable responses seen only in a small number of patients. The tumor microenvironment (TME) has been shown to be responsible for tumor immune escape and therapy fa...
Recent advancements in cancer immunotherapy have spotlighted the PD-1/PD-L1 pathway, crucial for its role in immune checkpoint regulation. Traditional inhi
Cancer immunotherapy represents a major advance in the cure of cancer following the dramatic advancements in the development and refinement of chemotherapies and radiotherapies. In the recent decades, together with the development of early diagnostic techniques, immunotherapy has significantly contributed to...
In this paper, we primarily focus on the recent advancements in TCR-T cell therapy, particularly within the last five years, including the discovery of novel targets, innovative protein engineering methods, ongoing and completed clinical trials, and the evolving trends of TCR-T cell therapy in ...
These advances include a better understanding of the genetic basis surrounding the development of endometrial cancer, novel surgical therapies, and new molecular targets for the treatment of this disease. This review explores the literature regarding these advancements in endometrial cancer. 展开 ...
Despite challenges, ongoing interdisciplinary collaborations and technological advancements offer hope for a future where lung cancer is treatable and preventable, reducing the burden on patients and healthcare systems worldwide. 展开 关键词: Lung cancer Research Comprehensive review Studies ...
Advancements in cancer therapy with alpha-emitters: a review Purpose: This synopsis attempts to shed light on the progresses made in the field of cancer therapy using α-particles. Hurdles and Progresses: The rationa... Seyed,K,Imam - International Journal of Radiation Oncology*Biology*Physics 被...
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last decade, significant advancements in the diagnosis and treatment of lung cancer, particularly NSCLC, have been achieved with the help of molecular translational research. Among the hopeful breakthroughs in the...
treatment of gastric cancer have been achieved with novel anti-HER2 therapeutic agents, such as T-DXd and disitamab vedotin (RC48) [16]. In addition, in light of the success of immunotherapy and targeted therapy as first-line treatments for advanced gastric cancer, ongoing research is ...